Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New shoulder block could beat standard pain method

NCT ID NCT07668648

Symptom relief Sponsor: Ferit Yetik Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times

Summary

This study compares two types of nerve blocks for pain after arthroscopic shoulder surgery. The standard block can sometimes cause temporary diaphragm paralysis. The newer block aims to provide similar pain relief with fewer risks. Eighty adults undergoing shoulder surgery will be randomly assigned to receive one of the two blocks, and their pain levels and opioid use will be tracked for 24 hours.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Bupivacaine
What this could lead to
If this trial succeeds, it could point toward a safer, equally effective pain-blocking method for shoulder surgery, reducing complications like diaphragm paralysis.
What could go wrong
This is a small, early-stage trial (80 participants) comparing two procedures. The newer block may not prove as effective, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 18 and 75 years * ASA physical status I, II, or III * Scheduled for elective arthroscopic shoulder surgery under general anesthesia * Provision of written informed consent Exclusion Criteria: * Refusal to participate in the study * Coagulopathy * Current anticoagulant therapy * Infection at the block site * Previous surgery involving the planned block site * Known allergy or history of toxicity to local anesthetics * Hepatic failure * Renal failure * Uncontrolled diabetes mellitus * Cognitive impairment or mental disability preventing reliable assessment * Chronic opioid use or ongoing chronic pain treatment * Pregnancy, suspected pregnancy, or breastfeeding * Chronic pulmonary disease (e.g., COPD or asthma) * Failed block

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Postoperative pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Postoperative pain Shoulder arthroscopy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Bursa City Hospital

    RECRUITING

    Bursa, Nilüfer, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.